Söndag 22 December | 02:26:07 Europe / Stockholm

Prenumeration

2024-11-28 10:35:00

Redeye provides a more in-depth review of AcouSort’s Q3 report, which did not include any major suprises besides lower sales and a better-then-expected cost control. We reiterate our fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/